Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
08/2005
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005CN1655780A Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
08/17/2005CN1654460A Continuous process for the preparation of pesticidal chlorothiazoles
08/17/2005CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
08/17/2005CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives
08/16/2005US6930131 Hetero or aromatic-alkyloxyalkylphenylsulfonamide or analogs or derivatives useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia
08/16/2005US6930111 Substituted heterocyclic compounds
08/11/2005WO2005073226A1 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
08/11/2005WO2005073203A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
08/11/2005WO2005073202A1 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005072731A1 3-phenyl-n- ((1, 3, 4) thiadiazol-2-yl) -acrylamide derivatives and related compounds as modulators of estrogen-related receptors for the treatment of e.g. cancer, rheumatoid arthritis or neurological disorders
08/11/2005WO2005072729A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/11/2005WO2005072681A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.
08/11/2005WO2005072132A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
08/11/2005WO2005058840A3 Method of coloring with capped diazotized compound and coupling component
08/11/2005WO2004110983A8 New benzamides as pparϒ modulators
08/11/2005WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof
08/11/2005US20050176965 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
08/11/2005US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde
08/11/2005US20050176789 Modulators of ATP-Binding Cassette transporters
08/11/2005US20050176788 Such as 2-[N-(4,5-dimethoxy-2-hydroxybenzoyl)amino]-4-[(2-diisopropylaminoethyl)aminocarbonyl]-1,3-thiazole; compounds relax gastric fundus, to relieve feeling of early satiety and bloating; gastrointestinal motility disorders
08/11/2005US20050176785 Process for preparing thiazole derivative and the intermediate compounds for preparing the same
08/11/2005US20050176780 2,5-disubstituted 3-mercaptopentanoic acid
08/11/2005US20050176776 Mitotic kinesin inhibitors
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050176749 Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/11/2005US20050176727 Male erectile dysfunction; 1-(3-chlorophenyl)-3-(4-pyridin-2-yl-piperazin-1-yl)propan-1-one O-methyloxime
08/11/2005US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis
08/11/2005US20050176709 Selective NPY (Y5) antagonists
08/11/2005US20050175554 as a UV filter in cosmetic preparation; skin and hair; R3-substituted 2-(4-aminophenyl)-benzothiazole by alkylation with the appropriate haloalkanes/haloaralkanes using a base
08/11/2005CA2553968A1 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
08/11/2005CA2551142A1 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
08/10/2005EP1318987B1 Process for resolution of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole and compounds therefor
08/10/2005EP1098891B1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653072A Broad -spectrum cephem compounds
08/10/2005CN1653055A Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
08/10/2005CN1652780A Diaminothiazoles used as CDK4 inhibitors
08/10/2005CN1652761A Preventive or therapeutic agent for kidney disease
08/10/2005CN1214084C Coating composition and method for preparing the same, and scuff-resistant plastic lens
08/10/2005CN1214040C Peptide derivatives having thiazolyl-alanine residue
08/09/2005US6927290 Production of mixed acid anhydride and amide compound
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005CA2231700C Prodrugs of aspartyl protease inhibitors
08/04/2005WO2005070921A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
08/04/2005WO2005070905A1 Antidiabetic oxazolidinediones and thiazolidinediones
08/04/2005WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005WO2005070042A2 Novel chemical compounds
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005035489A3 Improved synthesis of discodermolide and variants thereof
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171166 Use as inhibitors of FK560 binding proteins (FKBPs) enzyme activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injury or other related diseases
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171109 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171097 aryl is nitrogen heterocycyl; highly effective at a low dose and excellent in safety; farm and garden pests; 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile
08/04/2005CA2554188A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
08/04/2005CA2553966A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553831A1 Diamino alcohols and their use as renin inhibitors
08/04/2005CA2553405A1 Antidiabetic oxazolidinediones and thiazolidinediones
08/03/2005EP1559427A1 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1558593A1 Transition metal catalysts for (co)polymerizing olefinic monomers
08/03/2005EP1558592A1 Thiazol-(bi)cycloalkyl-carboxanilides
08/03/2005EP1558576A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
08/03/2005CN1649859A Substituted phenylacetamides and their use as glucokinase activators
08/03/2005CN1649854A Process for preparing thiazole derivative and the intermediate compounds for preparing the same
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649586A Heterocyclic amide derivatives for the treatment of diabetes and other diseases
08/03/2005CN1649585A Epothilone derivative for the treatment of hepatoma and other cancer diseases
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/02/2005US6925388 Heterocyclic nonnucleoside inhibitors of reverse transcriptase
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
08/02/2005US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068444A2 Thiazole derivatives and use thereof
07/28/2005WO2005068443A1 Acrylonitriles and pest controlling agents
07/28/2005WO2005068432A1 Malononitrile compound as pesticides
07/28/2005WO2005067502A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
07/28/2005WO2005048948A3 Urea derivatives as kinase modulators
07/28/2005US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase
07/28/2005US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165072 used as analgesics, antiepileptics agents, antidepressants, antiarrhythmia agents and for treatment of irritable bowel syndrome, Cnohn's disease, multiple sclerosis and bipolar disorders
07/28/2005US20050165069 Statine derivatives for the treatment of Alzheimer's disease
07/28/2005US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide
07/28/2005US20050165034 Novel heterocyclic derivatives of tripeptides and tripeptide mimetics; (+-)-2-[3-[(benzylsulfonyl)amino]-6-methyl-2-oxo-1 (2H)-pyridinyl]-N-[(4,5,6,7-tetrahydro-2H-indazole-5-yl]acetamide; anticoagulants